A new report describes the first successful attempt to grow an entire new
organ, transplant it into a recipient, and have it function normally.
by John
Tyburski
Copyright © Daily
Digest News, KPR Media, LLC. All rights reserved.
In a major
forward leap in regenerative medicine research, a group of British scientists
report that they have successfully grown a complete, functional organ from
harvested mouse cells. Even better, the new organ functioned normally after it
was transplanted into a recipient mouse.
Researchers
at the University of Edinburgh produced the world’s first working thymus, not
from stem cells but from connective tissue cells called fibroblasts. Although the
work was done entirely in mice, the success is nonetheless an extraordinary
achievement in regenerative medicine, which endeavors to one day be able to
replace diseased or injured organs with fresh ones grown in the lab.
Up to now,
only small portions of functional organs have been successfully grown in the
lab. Bits of hearts, livers, and even brains have been grown from stem cells,
but no complete, functional organs have been produced this way. In the new
study, the investigators created the new thymus from fibroblast cells, not stem
cells.
The thymus
gland is a kind of command center for the body’s immune system. Two kinds of
immune cells stop by the thymus to be armed and equipped to fight off foreign
invaders once they move back into the circulating blood. These so –called
T-cells, particularly CD4 or “helper” T-cells and CD8 or “killer” T-cells
orchestrate and carry out attacks on infected or abnormal cells, respectively.
The
Edinburgh scientists coaxed mouse fibroblast cells to overproduce a transcription
factor, or gene “switch” called FOXN1, which guides the formation of the thymus
during normal embryonic development. The fibroblasts with enhanced FOXN1 levels
transformed into induced thymic epithelial cells that when combined with other
supportive thymus cells and grafted onto the kidneys of mice, grew into
well-formed, structurally intact organs.
“This
research is an exciting early step towards that goal, and a convincing
demonstration of the potential power of direct reprogramming technology, by which
once cell type is converted to another,” said Dr Rob Buckle, Head of
Regenerative Medicine at the Medical Research Council, the source of funding
for the study. “However, much more work will be needed before this process can
be reproduced in the lab environment, and in a safe and tightly controlled way
suitable for use in humans.”
The
breakthrough accomplishment was published earlier this week in the journal Nature Cell
Biology.
No comments:
Post a Comment